Skip to main content

Advertisement

SpringerLink
Log in

Chymotrypsin Enhances Soluble Fms-Like Tyrosine Kinase 1 Production Through Protease-Activated Receptor 2 in Placenta-Derived Immortalized Human Trophoblast Cells

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

The production of soluble fms-like tyrosine kinase 1 (sFLT1) by exogenous chymotrypsin in trophoblast cells through protease-activated receptor (PAR) 2 was investigated to identify the role of a chymotrypsin-like serine protease in preeclampsia (PE) pathogenesis. We evaluated the expression of chymotrypsin, FLT1, and sFLT1 in monolayers of immortalized human trophoblast cells derived from placenta (TCL-1 cells). To investigate whether chymotrypsin enhances the production and release of sFLT1 through PAR-2, we examined changes in sFLT1 protein levels in conditioned medium by enzyme-linked immunosorbent assay and sFLT1 messenger RNA (mRNA) levels by real-time polymerase chain reaction in TCL-1 cells treated with exogenous chymotrypsin in the presence or absence of a PAR-2 antagonist or a chymotrypsin inhibitor (TPCK). We also examined changes in PAR-2 expression in TCL-1 cells treated with tumor necrosis factor (TNF) α in the presence or absence of a polyclonal anti-TNF-α antibody. Western blot analysis showed that TCL-1 trophoblast cells expressed chymotrypsin, FLT1, and sFLT1. Compared with the control cells, the sFLT1 level in the conditioned medium and sFLT1 mRNA level in cells were both significantly enhanced when treated with a PAR-2 agonist or chymotrypsin for 6 hours. In contrast, the sFLT1 level in the medium and sFLT1 mRNA level in cells treated with a PAR-2 agonist or chymotrypsin were suppressed in the presence of a PAR-2 antagonist or a chymotrypsin inhibitor. The PAR-2 expression was upregulated by TNF-α, which was suppressed in the presence of TNF-α antibodies. These results indicate that chymotrypsin-like serine protease enhances sFLT1 production through PAR-2 in trophoblast cells and thus plays an important additional role in PE pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abalos E, Cuesta C, Carroli G, et al. WHO multicountry survey on maternal and newborn health research network pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. Br J Obstet Gynecol. 2014;121(suppl 1):14–24.

    Article  Google Scholar 

  2. Brosens I. A study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies. J Obstet Gynecol Br Common. 1964;71:222–230.

    Article  CAS  Google Scholar 

  3. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension. 2007;50(6):1142–1147.

    Article  CAS  PubMed  Google Scholar 

  4. Nevo O, Soleymanlou N, Wu Y, et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol. 2006;291(4):R1085–R1093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cindrova-Davies T, Sanders DA, Burton GJ, Charnock-Jones DS. Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res. 2011;89(3):671–679.

    Article  CAS  PubMed  Google Scholar 

  6. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenic imbalance. Annu Rev Med. 2008;59:61–78.

    Article  CAS  PubMed  Google Scholar 

  7. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble FMS-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gu Y, Lewis DF, Wang Y. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab. 2008;93(1):260–266.

    Article  CAS  PubMed  Google Scholar 

  9. Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7(3):375–384.

    Article  CAS  PubMed  Google Scholar 

  10. Lim KH, Zhou Y, Janatpour M, et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol. 1997;151(6):1809–1818.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Salafia CM, Pezzullo JC, Ghidini A, Lopez-Zeno JA, Whittington SS. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta. 1998;19(1):67–72.

    Article  CAS  PubMed  Google Scholar 

  12. Sugimura M, Kobayashi T, Shu F, Kanayama N, Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta. 1999;20(7):555–660.

    Article  CAS  PubMed  Google Scholar 

  13. Sugimura M, Ohashi R, Kobayashi T, Kanayama N. Intraplacental coagulation in intrauterine growth restriction: cause or result? Semin Thromb Hemost. 2001;27(7):107–113.

    Article  CAS  PubMed  Google Scholar 

  14. Lockwood CJ, Toti P, Arcuri F, et al. Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua. Am J Pathol. 2007;170(4):1398–1405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhao Y, Koga K, Osuga Y, et al. Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia. Fertil Steril. 2012;98(4):917–921.

    Article  CAS  PubMed  Google Scholar 

  16. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407(6801):258–264.

    CAS  PubMed  Google Scholar 

  17. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. PAR3 is a cofactor for PAR4 activation by thrombin. Nature. 2000;404(6778):609–613.

    Article  CAS  PubMed  Google Scholar 

  18. Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells—comparison with the thrombin receptor. J Biol Chem. 1996;271(25):14910–1415.

    Article  CAS  PubMed  Google Scholar 

  19. O’Brien PJ, Prevost N, Molino M, et al. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem. 2000;275(18):13502–13509.

    Article  PubMed  Google Scholar 

  20. Kong W, McConalogue K, Khitin LM, et al. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci U S A. 1997;94(16):8884–8889.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A. 2000;97(10):5255–5260.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rothmeier AS, Ruf W. Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol. 2012;34(1):133–149.

    Article  CAS  PubMed  Google Scholar 

  23. Hutchinson ES, Brownbill P, Jones NW, et al. Utero-placental haemodynamics in the pathogenesis of pre-eclampsia. Placenta. 2009;30(7):634–641.

    Article  CAS  PubMed  Google Scholar 

  24. Lewis MP, Clements M, Takeda S, et al. Partial characterization of an immortalized human trophoblast cell-line, TCL-1, which possesses a CSF-1 autocrine loop. Placenta. 1996;17(2-3):137–46.

    Article  PubMed  Google Scholar 

  25. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;248(4952):220–223.

    Article  CAS  PubMed  Google Scholar 

  26. Kabir-Salmani M, Shiokawa S, Akimoto Y, et al. Alphavbeta3 integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration. Endocrinology. 2003;144(4):1620–1630.

    Article  CAS  PubMed  Google Scholar 

  27. Suga N, Sugimura M, Koshiishi T, et al. Heparin/heparan sulfate/CD44-v3 enhances cell migration in term placenta-derived immortalized human trophoblast cells. Biol Reprod. 2012;86(5):134, 1–8.

    Article  Google Scholar 

  28. Wang Y, Gu Y, Zhang Y, Lewis DF, Alexander JS, Granger DN. Increased chymotrypsin-like protease (chymase) expression and activity in placentas from women with preeclampsia. Placenta. 2007;28(4):263–269.

    Article  PubMed  Google Scholar 

  29. Munaut C, Lorquet S, Pequeux C, et al. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod. 2008;23(6):1407–1415.

    Article  CAS  PubMed  Google Scholar 

  30. Zhao S, Gu Y, Groome LJ, Cooper D, Wang Y. Proteases and sFlt-1 release in the human placenta. Placenta. 2010;31(6):512–518.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Sokolova E, Aleshin S, Reiser G. Expression of protease-activated receptor (PAR)-2, but not other PARs, is regulated by inflammatory cytokines in rat astrocytes. Neurochem Int. 2012;60(3):276–275.

    Article  CAS  PubMed  Google Scholar 

  32. Al-Ani B, Hewett PW, Cudmore MJ, et al. Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells. Hypertension. 2010;55(3):689–697.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, School of Medicine, Juntendo University, Tokyo, Japan

    Chihiro Hirai MD, Motoi Sugimura MD, PhD, Shintaro Makino MD, PhD & Satoru Takeda MD, PhD

  2. Department of Obstetrics, Gynecology and Family Medicine, School of Medicine, Hamamatsu University, Hamamatsu, Japan

    Motoi Sugimura MD, PhD

Authors
  1. Chihiro Hirai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Motoi Sugimura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shintaro Makino MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoru Takeda MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Motoi Sugimura MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hirai, C., Sugimura, M., Makino, S. et al. Chymotrypsin Enhances Soluble Fms-Like Tyrosine Kinase 1 Production Through Protease-Activated Receptor 2 in Placenta-Derived Immortalized Human Trophoblast Cells. Reprod. Sci. 23, 1542–1550 (2016). https://doi.org/10.1177/1933719116646203

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719116646203

Keywords

Search

Navigation